Medicine & Life Sciences
Ethiopia
100%
Visceral Leishmaniasis
85%
Guinea
47%
HIV
44%
Disease Outbreaks
35%
Ebola Hemorrhagic Fever
34%
Cambodia
32%
Cutaneous Leishmaniasis
26%
Sierra Leone
19%
Coinfection
18%
Belgium
16%
Zika Virus
15%
Leishmaniasis
15%
Therapeutics
15%
Hepacivirus
14%
Routine Diagnostic Tests
14%
Tuberculosis
14%
HIV Infections
13%
Malaria
13%
Myanmar
12%
Chikungunya virus
12%
Retrospective Studies
12%
Democratic Republic of the Congo
12%
Polymerase Chain Reaction
12%
Hepatitis C
12%
Cohort Studies
11%
miltefosine
11%
Leishmania
11%
Recurrence
11%
Eastern Africa
10%
Schistosomiasis
10%
Clinical Trials
10%
Microscopy
10%
Genotype
10%
Pentamidine
10%
Zika Virus Infection
10%
Cross-Sectional Studies
9%
Fever
9%
Elephantiasis
9%
Neglected Diseases
8%
Africa South of the Sahara
8%
liposomal amphotericin B
8%
Antibodies
8%
Mortality
8%
Paromomycin
8%
Antimony Sodium Gluconate
8%
Referral and Consultation
7%
Antigens
7%
Leprosy
7%
Child
7%
Health Facilities
7%
Aspirations (Psychology)
7%
Vaccines
7%
Treatment Failure
6%
Virus Diseases
6%
Survivors
6%
Aruba
6%
Infection
6%
Skin
6%
Enzyme-Linked Immunosorbent Assay
6%
Confidence Intervals
6%
CD4 Lymphocyte Count
6%
Monkeypox virus
6%
Epidemics
6%
Sensitivity and Specificity
6%
Safety
6%
picaridin
6%
Monkeypox
6%
Anti-Bacterial Agents
6%
Schistosoma
5%
Pandemics
5%
Delivery of Health Care
5%
Tropical Medicine
5%
Evaluation Studies
5%
2-(pyrrolidin-2-yl)-5-(2-(4-(5-(pyrrolidin-2-yl)-1H-imidazol-2-yl)phenyl)benzofuran-5-yl)-1H-imidazole
5%
MK-5172
5%
Guidelines
5%
Mass Drug Administration
5%
Insect Repellents
5%
Sudan
5%
Emergencies
5%